Sign up
Healthed-White-on-Blue

Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

Description

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

This Product Explainer is supported by CSL Seqirus

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Debbie Rigby

A/Prof Debbie Rigby

Why Inhaler Device Design and Technique Matters

Dr Philip Tong

Dr Philip Tong

Facial Rashes Case Studies – Practical Guide to Assessment and Management

Dr Rupert Hinds

Dr Rupert Hinds

Abdominal Pain in Children – Practical Approach in GP

Prof Roger Chen

Prof Roger Chen

Practical Guide to Improving Control of T2D

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

09 June 2026
Register Now
Prof Richard Harvey

expert

Prof Richard Harvey

Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon, Macquarie University, St Vincent's Hospitals, Sydney; Program Head, Rhinology & Skull Base Surgery, Applied Medical Research Center, UNSW; Professor, UNSW, Macquarie University

Date published: 24 October 2023

Discover

Healthed

CPD platform